TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Profit & Loss Account Balance History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Profit & Loss Account Balance | ₹4,747 Cr | ₹3,942 Cr | ₹3,303 Cr | ₹2,917 Cr | ₹2,806 Cr |
What is the latest Profit & Loss Account Balance ratio of TORRENT PHARMACEUTICALS ?
Year | Profit & Loss Account Balance |
---|---|
Mar2025 | ₹4,747 Cr |
Mar2024 | ₹3,942 Cr |
Mar2023 | ₹3,303 Cr |
Mar2022 | ₹2,917 Cr |
Mar2021 | ₹2,806 Cr |
How is Profit & Loss Account Balance of TORRENT PHARMACEUTICALS Trending?
Years | Profit & Loss Account Balance | % Change | |
---|---|---|---|
Mar2025 | ₹4,747 Cr | 20.40 | |
Mar2024 | ₹3,942 Cr | 19.35 | |
Mar2023 | ₹3,303 Cr | 13.25 | |
Mar2022 | ₹2,917 Cr | 3.93 | |
Mar2021 | ₹2,806 Cr | - |
Compare Profit & Loss Account Balance of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹120,683.6 Cr | NA | -0.9% | 4.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹387,792.0 Cr | 0.9% | -0.2% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,986.0 Cr | 0.1% | 0.4% | 16.6% | Stock Analytics | |
CIPLA | ₹127,124.0 Cr | 0.5% | 3.8% | -3.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,868.0 Cr | 2.8% | 6.9% | -2% | Stock Analytics | |
MANKIND PHARMA | ₹106,486.0 Cr | 1.8% | 6.6% | 8.2% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | NA |
-0.9% |
4.9% |
SENSEX | 1.5% |
1.6% |
0.4% |
You may also like the below Video Courses